Weekly News Amount
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
RecBio is a research and development company of genetic engineering vaccine for major diseases, which is committed to the innovation and industrialization of genetic engineering vaccine for major diseases, and has an innovative research and development technology platform for protein engineering and new adjuvant technology. At present, RuiKeShengWu has several product lines with market capacity of tens of billions represented by HPV series vaccines, recombinant herpes zoster virus vaccines, tuberculosis vaccines and recombinant COVID-19 vaccines, which are in different research and development stages


Funding 1 Fundings


Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info


Intelligence 0 Research Briefs


Competitors 0 Competitors